Ultrasound imaging of fasciitis due to body-building supplement

American Journal of the Medical Sciences

Volumn 335, Issue 3, 2008, Pages 242-245

  Rozin, Alexander P ^a,b   Schapira, Daniel ^a   Braun Moscovici, Yolanda ^a   Markovits, Doron ^a   Vlodavsky, Eugene ^a   Balbir Gurman, Alexandra ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Rambam Health Care Campus ^*  (Israel)

Author keywords

Body building supplement; Brachioradial fascia thickness of healthy control subjects; Corticosteroids; Fasciitis; Sonography

Indexed keywords

CORTICOSTEROID; TRYPTOPHAN;

ADULT; ARTICLE; BODY BUILDING; BODY MASS; CAPILLAROSCOPY; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ECHOGRAPHY; FASCIITIS; HUMAN; HUMAN TISSUE; LABORATORY TEST; PANNICULITIS; PHYSICAL EXAMINATION; SKIN BIOPSY; TREATMENT OUTCOME; ULTRASOUND; WHEY;

EID: 40949090194     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3180ed454c     Document Type: Article

References (16)

1. Chan V, Soans B, Mathers D. Ultrasound and magnetic resonance imaging features in a patient with eosinophilic fasciitis. Australas Radiol 2004;48:414-7.
2. Pillen S, van Engelen B, van den Hoogen F, et al. Eosinophilic fasciitis in a child mimicking a myopathy. Neuromuscul Disord 2006;16:144-8.
3. Belongia EA, Gleich GJ. Eosinophilia-myalgia syndrome revisited. J Rheum 1996;23:1682-5.
4. Belongia EA, Hedberg CW, Gleich GJ, et al. An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med 1990;323:357-65.
5. Viallard JF, Taupin JL, Ranchin V, et al. Analysis of leukemia inhibitory factor, type 1 and type 2 cytokine production in patients with eosinophilic fasciitis. J Rheumatol 2001;28:75-80.
6. Noakes R, Spelman L, Williamson R. Is the L-tryptophan metabolite quinolinic acid responsible for eosinophilic fasciitis? Clin Exp Med 2006;6:60-4.
7. Misumi M, Ideguchi H, Tuji T, et al. Case of eosinophil fasciitis with change of serum Th1/Th2 cytokine level, which correlated with disease activity. Niho Rinsko Meneki Gakkai Kaishi 2002;25:263-9.
8. Shulman LE. Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians 1975;88:70-86.
9. Lamloum M, Sioud DA, Ben Ghorbel I, et al. Shulman syndrome: a report of 4 cases and review of the literature. Tunis Med 2006;84:189-94.
10. Antic M, Lautenschlager S, Itin PH. Eosinophilic fasciitis 30 years after: what do we really know? Report of 11 patients and review of the literature. Dermatology 2006;213:93-101.
11. Schaffer JV. The changing face of graft-versus-host disease. Semin Cutan Med Surg 2006;25:190-200.
12. Clauw DJ, Crofford LJ. Eosinophilic rheumatic disorders. Rheum Dis Clin North Am 1995;21:231-46.
13. Hertzman PA. The eosinophilia-myalgia syndrome: opportunities realized and missed. J Rheum 1996;23:1679-81.
14. Spitzer WO, Haggerty J, Berkson L, et al. Continuing occurrences of eosinophilia myalgia syndrome in Canada. Br J Rheumatol 1995;34:246-51.
15. Kilbourne EM. Eosinophilia-myalgia syndrome: coming to grips with a new illness. Epidemiol Rev 1992;14:16-36.
16. Rozin A, Bishara B, Ben-Izhak O, et al. Fibrosing omental panniculitis and polyserositis associated with long-term treatment by paroxetine. Isr Med Assoc J 2000;2:714-6.